Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo Buys Okairos for $324 Million to Grow in Vaccines
Glaxo Buys Okairos for $324 Million to Grow in Vaccines
Glaxo Buys Okairos for $324 Million to Grow in Vaccines
Submitted by
admin
on May 29, 2013 - 8:23am
Source:
Bloomberg
News Tags:
GSK
vaccines
Okairos
M&A
Headline:
Glaxo Buys Okairos for $324 Million to Grow in Vaccines
Do Not Allow Advertisers to Use My Personal information
